$425 Million is the total value of Clarus Ventures, LLC's 10 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVRO | AvroBio Inc. | $153,656,000 | +81.6% | 2,962,325 | 0.0% | 36.11% | +20.0% | |
| NSTG | Buy | Nanostring Technologies Inc. | $71,962,000 | +32.9% | 4,036,025 | +1.9% | 16.91% | -12.2% |
| SIEN | Sientra Inc. | $65,211,000 | +22.4% | 2,730,765 | 0.0% | 15.33% | -19.1% | |
| FTSV | Forty Seven Inc | $56,949,000 | -6.7% | 3,816,951 | 0.0% | 13.38% | -38.4% | |
| GRTS | New | Gritstone Oncology Inc | $36,560,000 | – | 2,567,445 | +100.0% | 8.59% | – |
| ETTX | New | Entasis Therapeutics Holdings Inc | $17,663,000 | – | 1,623,405 | +100.0% | 4.15% | – |
| HAIR | Restoration Robotics Inc. | $10,353,000 | -16.4% | 3,569,986 | 0.0% | 2.43% | -44.8% | |
| VBIV | VBI Vaccines Inc. | $6,512,000 | -12.0% | 2,691,042 | 0.0% | 1.53% | -41.8% | |
| EPIX | ESSA Pharma Inc. | $5,006,000 | -20.8% | 1,668,560 | 0.0% | 1.18% | -47.7% | |
| CATB | Catabasis Pharmaceuticals Inc. | $1,606,000 | -16.6% | 2,008,192 | 0.0% | 0.38% | -45.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Nanostring Technologies Inc. | 20 | Q3 2018 | 60.2% |
| Sientra Inc. | 16 | Q3 2018 | 38.2% |
| Oxford Immunotex Global PLC | 14 | Q1 2017 | 17.4% |
| Catabasis Pharmaceuticals Inc. | 14 | Q3 2018 | 15.3% |
| VBI Vaccines Inc. | 10 | Q3 2018 | 11.4% |
| TetraLogic Pharmaceuticals Corporation | 9 | Q4 2015 | 12.5% |
| ESSA Pharma Inc. | 9 | Q1 2018 | 6.5% |
| Aerie Pharmaceuticals Inc. | 7 | Q4 2015 | 30.5% |
| VBI Vaccines Inc. | 7 | Q1 2016 | 9.1% |
| Ophthotech Corp | 6 | Q1 2015 | 31.5% |
View Clarus Ventures, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-NT | 2024-08-14 |
| 13F-NT | 2024-05-15 |
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
| 13F-NT | 2023-05-15 |
| 13F-NT | 2023-02-14 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-15 |
View Clarus Ventures, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.